AL

Alban Lepetitcolin

Unit Head Mrna Process Development | Coe Mrna | Sanofi at Sanofi

Alban Lepetitcolin is an accomplished professional with extensive experience in mRNA vaccines and bioconjugate chemistry. Currently serving as the Unit Head for mRNA Process Development at Sanofi since August 2019, Alban leads a technical team focused on the development of mRNA vaccine drug substance processes. Previous roles at Sanofi Pasteur included contributions to R&D in downstream processing for bioconjugate vaccines, where Alban gained expertise in purification development and process transfer. Earlier experiences involve work in organic synthesis and analysis at renowned institutions such as CNRS and Imperial College London. Alban holds multiple degrees in pharmacy and chemistry, including a Doctor of Pharmacy from Université Clermont Auvergne and a Chemistry Engineer degree from SIGMA Clermont.

Links

Previous companies

CNRS logo
Imperial College London logo

Org chart

This person is not in the org chart


Teams

This person is not in any teams